M&A · Healthcare · Buyer's industry: Services-Commercial Physical & Biological Research
Incyte Corp to acquire Vega Therapeutics
Announced Jun 8, 2026 · Closed Jul 6, 2026 · Private target
Deal value$1.25B
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- Incyte Corp (INCY)
- Target
- Vega Therapeutics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Jul 6, 2026
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Lazard
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Services-Commercial Physical & Biological Research